VeriMomHamilelikte retinoyl oligopeptide-112 kullanmaktan kaçınmalı mıyım? | VeriMom
No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- retinoyl oligopeptide-112 hamilelikte güvenli mi?
- No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
- retinoyl oligopeptide-112 emzirirken güvenli mi?
- No specific data on milk excretion for this ingredient were located. Topical retinoids are generally advised against in pregnancy and often avoided during breastfeeding as a precaution; because the compound contains a retinoyl group there is a class‑based/theoretical concern (h=1, m=1). Measured systemic absorption for retinoid‑peptide conjugates was not found, so exposure scored as low but measurable (e=1).
- retinoyl oligopeptide-112 bebek cildi için güvenli mi?
- Infant skin has higher permeability; per your rules increase exposure by +1 when adult exposure is measurable. No infant‑specific safety data were found for Retinoyl Oligopeptide‑112; therefore h and m remain the same as adults (structural/class concern), and e is increased to 2 for 0–3‑year‑old skin. Keep infants’ direct contact with treated skin minimal (no application to chest/areas the baby may contact) in the absence of data.
- VeriMom retinoyl oligopeptide-112 nasıl puanlıyor?
- VeriMom retinoyl oligopeptide-112'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 13/100 (yüksek risk) olarak puanlar.
- Hamilelikte retinoyl oligopeptide-112 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.